MHRA approves new treatment for severe alopecia areata
12th March 2026 Uncategorised 0Regulator authorises deuruxolitinib for adults with extensive hair loss More: MHRA approves new treatment for severe alopecia areata Source: News
read more
Regulator authorises deuruxolitinib for adults with extensive hair loss More: MHRA approves new treatment for severe alopecia areata Source: News
read more
Study aims to advance treatment options for severe peripheral arterial disease More: Aplagon doses first patient in phase 2a trial of APAC Source: News
read moreWhile much of the company’s recent focus has remained on beefing up its U.S. infrastructure, Eli Lilly has for the second time this week made moves to raise capacity for its medicines overseas, and once again in Asia. More: After
read moreDuring a quarterly conference call, executives from Legend Biotech showed little concern for a potential threat to its lone commercial product, multiple myeloma CAR-T Carvykti. Oddly enough, the threat is coming from its Carvykti parter, Johnson & Johnson, and its
read moreThe new platform combines seven different adverse event dashboards into one, an effort that could save the agency $120 million over five years, it said. More: FDA rolls out new streamlined adverse event monitoring system, eyes 0M in savings Source:
read moreAccording to a new team-up between Eisai and Pokémon, when it comes to healthy sleep habits, people of all ages have gotta catch ’em all. More: Eisai chooses 'Pokémon Sleep' app to battle bad sleep habits in awareness campaign Source:
read more© 1994 - 2026 B.M. Pharmaceuticals